# Neutec Ar-Ge San ve Tic A.Ş clinical trials: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials with Neutec Ar-Ge San ve Tic A.Ş as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Neutec Ar-Ge San ve Tic A.Ş: 20 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/neutec-ar-ge-san-ve-tic-a

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 15, 2023 | NCT06040424 | Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in... | Neutec Ar-Ge San ve Tic A.Ş | Phase 3 | Unknown | COPD | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06040424) |
| June 6, 2023 | NCT05890638 | Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser... | Neutec Ar-Ge San ve Tic A.Ş | Phase 3 | Unknown | COPD | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05890638) |
| July 7, 2020 | NCT04457323 | S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients. | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Unknown | Hypertension | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04457323) |
| June 25, 2020 | NCT04446637 | Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium... | Neutec Ar-Ge San ve Tic A.Ş | Phase 3 | Withdrawn | Chronic Obstructive Pulmonary Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04446637) |
| May 17, 2019 | NCT03954613 | Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Unknown | Alzheimer Disease, Cognitive Change | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03954613) |
| November 2, 2018 | NCT03729258 | Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis. | Neutec Ar-Ge San ve Tic A.Ş | Phase 3 | Unknown | Sinusitis, Sinusitis, Acute, Rhinosinusitis, Rhinosinusitis Acute, Sinus Infection | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03729258) |
| January 17, 2018 | NCT03400735 | Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adults | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Unknown | Acute Exacerbation of Chronic Bronchitis, Community-Acquired Pneumoniae | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03400735) |
| January 9, 2018 | NCT03395002 | Tiotropium/Salmeterol/Fluticasone Fixed Dose Combination Tratment Via Discair vs Tiotropium Via Handihaler + Salmeterol/Fluticasone Via... | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | COPD | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03395002) |
| January 3, 2018 | NCT03388853 | Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD. | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | COPD | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03388853) |
| December 6, 2017 | NCT03363503 | Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Terminated | COPD | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03363503) |
| November 28, 2017 | NCT03355170 | Cardiac Safety of Lansoprazole and Domperidon Combination | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Withdrawn | GERD, Cardiac Event, Safety Issues | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03355170) |
| June 6, 2017 | NCT03177746 | The Safety of Dapoxetine/Tadalafil Combination Therapy | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Unknown | Premature Ejaculation, Erectile Dysfunction, Safety Issues | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03177746) |
| January 31, 2017 | NCT03038451 | Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | Hypertension | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03038451) |
| January 31, 2017 | NCT03037606 | Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | Gastroesophageal Reflux Disease | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03037606) |
| January 23, 2017 | NCT03028701 | Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | Copd | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03028701) |
| December 9, 2016 | NCT02988869 | Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | COPD | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02988869) |
| November 8, 2016 | NCT02958046 | The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | Gastroesophageal Reflux Disease | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02958046) |
| October 20, 2016 | NCT02939495 | The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | Premature Ejaculation, Erectile Dysfunction | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02939495) |
| February 24, 2016 | NCT02689999 | The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | Gastroesophageal Reflux Disease (GERD) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02689999) |
| September 4, 2015 | NCT02541006 | Comparison of 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in... | Neutec Ar-Ge San ve Tic A.Ş | Phase 4 | Completed | COPD | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02541006) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 3 | 4 |
| Phase 4 | 16 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 10 |
| Unknown | 7 |
| Withdrawn | 2 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pulmonary Disease, Chronic Obstructive | 9 |
| Gastroesophageal Reflux | 4 |
| Hypertension | 2 |
| Premature Ejaculation | 2 |
| Erectile Dysfunction | 2 |
| Sinusitis | 1 |
| Rhinosinusitis | 1 |
| Alzheimer Disease | 1 |
| Cardiovascular Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Medical service organizations in the United States](https://specstream.ai/data/businesses/medical-service-organizations/united-states)
- [Mills in the United States](https://specstream.ai/data/businesses/mills/united-states)
- [Nepalese restaurants in the United States](https://specstream.ai/data/businesses/nepalese-restaurants/united-states)
- [Office supply stores in the United States](https://specstream.ai/data/businesses/office-supply-stores/united-states)
- [Outpatient care facilities in the United States](https://specstream.ai/data/businesses/outpatient-care-facilities/united-states)
- [Payroll companies in the United States](https://specstream.ai/data/businesses/payroll-companies/united-states)
